Shots:
- AI is moving drug development from computation to clinical confidence, showing how it now guides target discovery, molecule design, patient stratification, and trial planning while turning fragmented biomedical data into decision-ready insight that reduces risk, cost, and failure rates.
- Trust, transparency, and regulation define AI’s real breakthrough, as the focus shifts beyond speed toward explainable models, validated predictions, strong data governance, and alignment with FDA and EMA expectations where credibility, not novelty, becomes the true currency of AI-driven R&D.
- The magazine showcases real-world AI innovation in action, including Valo Health’s human-data–driven discovery platform, evolving biopharma–tech partnerships, leadership perspectives shaping AI strategy, regulatory viewpoints on data use, and industry snapshots that connect computational progress with measurable patient and business impact
Get a chance to advertise with us! Send us your promotional pieces at connect@pharmashots.com
